Table 3.
Baseline laboratory characteristics of the study participants.
| Variable | Control group (n = 66) | CSF group (n = 66) | P value |
|---|---|---|---|
| WBC (109/L) | 5.9 ± 1.2 | 6.1 ± 1.3 | 0.3601 |
| Blood glucose | 10.42 ± 0.63 | 10.57 ± 0.58 | 0.1571 |
| HDL-C (mmol/L) | 1.12 ± 0.25 | 1.18 ± 0.28 | 0.1964 |
| LDL-C (mmol/L) | 2.63 ± 0.73 | 2.53 ± 0.65 | 0.4074 |
| TG (mmol/L) | 1.48 ± 1.12 | 1.46 ± 1.16 | 0.9199 |
| TC (mmol/L) | 4.21 ± 0.68 | 4.24 ± 0.72 | 0.8060 |
| Serum creatinine (umol/L) | 58.62 ± 12.36 | 58.73 ± 11.43 | 0.9577 |
| Cystatin C (mg/L) | 0.92 ± 0.25 | 0.87 ± 0.28 | 0.2812 |
| hs-CRP (mg/L) | 1.91 ± 0.61 | 3.01 ± 1.16 | <0.001 |
| miRNA-155 | 0.09 ± 0.05 | 0.23 ± 0.09 | <0.001 |
Variables measured with number of patients (percentages in parentheses or mean ± SD). CSF: coronary slow flow; WBC: white blood cells; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; TC: total cholesterol; hs-CRP: high-sensitivity C-reactive protein.